Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

159.98
+1.961.24%
Post-market: 159.89-0.0900-0.06%19:30 EDT
Volume:998.18K
Turnover:159.38M
Market Cap:305.24B
PE:24.19
High:160.29
Open:158.51
Low:157.83
Close:158.02
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.68
T/O Rate:0.05%
Dividend:4.67
Dividend Rate:2.92%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.35
PE(LYR):22.37

Loading ...

Novartis Returns to Growth After Key Drugs Offset Patent Expirations

Dow Jones
·
Jul 21

Key Drug Sales Drive Novartis Back to Revenue Growth

Deep News
·
Jul 21

Stocks to Watch: GM, Novartis, Swatch, Micron

Dow Jones
·
Jul 21

Movement Alert|Novartis Rises 3.58% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations Signaling Growth Recovery

Market Focus
·
Jul 21

Novartis Guidance Points to Slow Second Half

Dow Jones
·
Jul 21

Novartis Q2 Core Earnings Down, Sales Rise

MT Newswires Live
·
Jul 21

Novartis Benefits from Timing Effects That Will Drag Next Results

Dow Jones
·
Jul 21

Movement Alert|Novartis Overnight Rise 3.47%, Q2 Earnings Significantly Beat Expectations Signaling Return to Growth

Market Focus
·
Jul 21

Novartis Beats Expectations, but Guidance Reiteration Surprises

Dow Jones
·
Jul 21

Novartis Q2 Results Exceed Expectations as Strong Sales of Innovative Drugs Offset Generic Competition, Signaling Return to Growth

Stock News
·
Jul 21

Novartis Q2 Adj. EPS $2.41 Beats $2.13 Estimate, Sales $14.408B Beat $14.042B Estimate

Benzinga Earnings
·
Jul 21

Novartis Recovery Prospects, Drug Pipeline in Focus

Dow Jones
·
Jul 20

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

Novartis' Fabhalta Receives FDA Traditional Approval for Primary IgA Nephropathy

MT Newswires Live
·
Jul 17

Novartis AG Expected to Post Earnings of $2.15 a Share - Earnings Preview

Reuters
·
Jul 17

Why Abbott Stock is Having Its Best Day in 24 Years

Dow Jones
·
Jul 16

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
Jul 16

Novartis Results to Show Effects of Patent Expiration, Acquisitions

Dow Jones
·
Jul 15

Earning Preview: Novartis AG this quarter’s revenue is expected to decrease by 2.14%, and institutional views are bullish

Earnings Agent
·
Jul 14

Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy

MT Newswires Live
·
Jul 14